Infect Chemother.  2020 Mar;52(1):98-104. 10.3947/ic.2020.52.1.98.

Neutropenic Enterocolitis due to Mucormycosis in a Patient with Myelodysplastic Syndrome

Affiliations
  • 1Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
  • 2Division of Hematology-Oncology, Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea
  • 3Division of Infectious Diseases, Department of Internal Medicine, Pusan National University School of Medicine and Medical Research Institute, Pusan National University Hospital, Busan, Korea

Abstract

Neutropenic enterocolitis is a fatal enterocolitis occurring in neutropenic patients with immunocompromised diseases including hematologic malignancies. Gastrointestinal (GI) mucormycosis in hematologic malignancies has been rarely reported. Especially, in myelodysplastic syndrome (MDS), GI mucormycosis has never been reported. We report a case of GI mucormocysis manifesting as neutropenic enterocolitis in a patient with MDS.

Keyword

Gastrointestinal mucormycosis; Neutropenia; Myelodysplastic syndrome

Figure

  • Figure 1 Time course of antibiotics.

  • Figure 2 Abnormal wall thickening and decreased density of the ileocecal valve and terminal ileum, suggesting necrotizing enterocolitis (white arrows).

  • Figure 3 Perforation of the ileocecal valve (white arrows), terminal ileum with partial obstruction, and peritonitis.

  • Figure 4 Histological observations. (A) Microscopically extensive coagulative infarction of intestine was noticed and angioinvasion (arrow head) in the muscularis propria was identified (H&E, ×40). (B) Fungal hyphae were admixed with fibrinous material in the vascular lumen occluding the vasculature, which is referred to angioinvasion (H&E, ×200). (C) GMS staining demonstrated non-septated broad hyphae with right-angled branching, suggestive of invasive mucormycosis (GMS, ×200).H&E, hematoxylin and eosin; GMS, Gomori's methenamine silver.

  • Figure 5 Computed tomography abdominal scan showed perforation of terminal ileum at the ileocecal valve with gangrenous change and multifocal fluid collection in the peritoneum (white arrows).

  • Figure 6 Presence of (A) transmural infarction (H&E, ×40) with (B) fungal hyphae (Periodic acid-Schiff, ×400).H&E, hematoxylin and eosin.


Cited by  1 articles

Advances in prophylaxis and treatment of invasive fungal infections: perspectives on hematologic diseases
Hyojin Ahn, Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee
Blood Res. 2022;57(S1):101-111.    doi: 10.5045/br.2022.2022036.


Reference

1. Rodrigues FG, Dasilva G, Wexner SD. Neutropenic enterocolitis. World J Gastroenterol. 2017; 23:42–47. PMID: 28104979.
Article
2. Urbach DR, Rotstein OD. Typhlitis. Can J Surg. 1999; 42:415–419. PMID: 10593241.
3. Yi HS, Sym SJ, Park J, Cho EK, Shin DB, Lee JH. Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia. Leuk Res. 2010; 34:e173–5. PMID: 20074799.
Article
4. Suh IW, Park CS, Lee MS, Lee JH, Chang MS, Woo JH, Lee IC, Ryu JS. Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia. J Korean Med Sci. 2000; 15:351–354. PMID: 10895981.
Article
5. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54(Suppl 1):S16–S22. PMID: 22247441.
Article
6. Lee ZJ, Chia C, Busmani I, Wong WK. A rare cause of ischemic gut: a case report. Int J Surg Case Rep. 2016; 20:114–117. PMID: 26852360.
Article
7. Spellberg B. Gastrointestinal mucormycosis: an evolving disease. Gastroenterol Hepatol (N Y). 2012; 8:140–142. PMID: 22485085.
8. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Picardi M, Corvatta L, D'Antonio D, Girmenia C, Martino P, Del Favero A. GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) Infection Program. Mucormycosis in hematologic patients. Haematologica. 2004; 89:207–214. PMID: 15003897.
9. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41:634–653. PMID: 16080086.
Article
10. Forrester JD, Chandra V, Shelton AA, Weiser TG. Gastrointestinal mucormycosis requiring surgery in adults with hematologic malignant tumors: literature review. Surg Infect (Larchmt). 2015; 16:194–202. PMID: 25405775.
Article
11. Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013; 56:711–717. PMID: 23196957.
Article
12. Lo OS, Law WL. Ileocolonic mucormycosis in adult immunocompromised patients: a surgeon's perspective. World J Gastroenterol. 2010; 16:1165–1170. PMID: 20205292.
Article
13. Han JY, Cheon JH, Kim DH, Chon HJ, Kim SK, Kim TI, Min YH, Kim WH. Ileal mucormycosis diagnosed by colonoscopy in a patient with acute myeloid leukemia. Korean J Gastroenterol. 2008; 52:179–182. PMID: 19077514.
14. Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL. European Conference on Infections in Leukemia. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica. 2013; 98:492–504. PMID: 22983580.
Article
15. Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G. European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group. European Confederation of Medical Mycology. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect. 2014; 20(Suppl 3):5–26.
Article
16. Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K. Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol. 2010; 48:245–254. PMID: 19568978.
Article
17. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis. 2012; 54(Suppl 1):S55–S60. PMID: 22247446.
Article
18. Schutte KM, Baddour LM. Gastrointestinal mucormycosis in patients with hematologic malignancy. Infect Dis Clin Pract. 2014; 22:18–25.
Article
19. Lee S, Yun NR, Kim KH, Jeon JH, Kim EC, Chung DH, Park WB, Oh MD. Discrepancy between histology and culture in filamentous fungal infections. Med Mycol. 2010; 48:886–888. PMID: 20092421.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr